Integra LifeSciences Announces Definitive Agreement To Acquire ACell, Inc. View details
ACell’s platform MatriStem UBM™ technology facilitates the body’s ability to remodel functional tissue1. Our mission is to leverage that technology to help patients around the world.
As the healthcare system continues to respond to the COVID-19 pandemic, ACell remains ready to support our customers and their patients with solutions for acute soft tissue reconstruction.
These new 16 x 25 cm and 16 x 35 cm sheets provide full coverage for areas of extensive tissue loss as one of the largest wound management device footprints on the market.
Visit our on-demand library of webinars led by clinical experts showcasing how ACell products are used to treat patients with complex cases.
Now offering two larger sizes in the Cytal Wound Matrix 3-Layer product line. These additional sizes will provide larger coverage for areas with extensive tissue loss.
Gentrix is a resorbable, non-crosslinked surgical device designed to strengthen and support the repair of soft tissue defects including ventral, parastomal, and hiatal hernias.
MicroMatrix is an easy to apply, fully-resorbable particulate that provides intimate contact with wounds and is ideal for irregular or tunneling wounds.
Cytal is a highly conformable, pre-fenestrated sheet that is available in multiple sizes and thicknesses to allow for tailored wound management.
ABRA System pulls muscle planes and skin together from their lateral retracted state with dynamic appositional traction facilitating primary closure.
Cytal Burn Matrix devices are non-crosslinked scaffolds that allow for the repair and remodeling of soft tissue that has been damaged by second degree burns.
Access information on product ordering, reimbursement, and professional education opportunities.
ACell is a leading regenerative medicine company that develops and manufactures products designed to facilitate the body’s ability to remodel site-appropriate tissue.
ACell Inc.